Novartis / HBV / GlaxoSmithKline / B. Management / Pharmasset / Bristol-Myers Squibb / Amazon / Wang SA / Medline / Schering / Wiley InterScience / Alteon Inc. / /
Continent
Africa / Asia / South America / /
Country
Hungary / Ecuador / Greenland / Venezuela / Guatemala / Cyprus / Peru / Honduras / Colombia / Brazil / Suriname / Guyana / Canada / Malta / Israel / Haiti / Dominica / United States / Jamaica / Bolivia / Spain / Antigua and Barbuda / / /
Event
FDA Phase / M&A / /
Facility
University of Michigan Medical Center / Alaska Native Medical Center / Heathcote / American College of Physicians Manual / University of Michigan Health System / / /
IndustryTerm
prevention of HBV / inactive carrier state / carrier state / food / satellite virus / treatment for HBV / younger carrier / carrier mothers / Prevention of Hepatitis B / /
MedicalCondition
acute hepatitis B / sexually transmitted disease / Chronic necroinflammatory disease / HIV / cirrhosis / hepatitis B / stage liver disease / hepatitis / liver disease / hepatic decompensation / already developed cirrhosis / AASLD PRACTICE GUIDELINE UPDATE Chronic Hepatitis B / 2Liver Disease / cancer / hepatocellular carcinoma / Resolved hepatitis B / Chronic hepatitis B. HEPATOLOGY / progressive liver disease / HCV / superinfection / AASLD PRACTICE GUIDELINES Chronic Hepatitis B / hepatitis D / virus infection / portal hypertension / severe hepatitis / AIDS / infection / chronic hepatitis / chronic hepatitis B. However / prior infection / chronic infection / renal failure / HBeAg-positive chronic hepatitis B / moderate/severe inflammation / hepatitis B. They / active necroinflammatory disease / fibrosis / hepatitis A / cuts / Fanconi syndrome / significant fibrosis / undetectable serum hepatitis B / hepatitis C / HDV infection / HDV superinfection / severe liver disease / Liver biopsy showing chronic hepatitis / HBeAg-negative chronic hepatitis B / significant / ongoing necroinflammatory disease / HIV infection / Coexistent HCV infection / disease / concurrent hepatitis B / chronic liver disease / severe acute hepatitis / recurrent hepatitis B / Although cirrhosis / concurrent infection / HBeAgnegative chronic hepatitis B / hepatic failure / persistent infection / osteomalacia / resolved hepatitis B. HBeAg / certain opportunistic infections / hepatitis B. In / advanced liver disease / chronic hepatitis B. Management / active virus infection / Chronic Hepatitis B / /
University of Michigan Medical Center / Division of Gastroenterology / Advisory Committee on Immunization Practices / Practice Guidelines Committee / American Association for the Study of Liver Diseases / National Institute of Health / Alaska Native Medical Center / University of Michigan Health System / Infectious Diseases Society of America / Taubman Center / Centers for Disease Control and Prevention / U.S. Food and Drug Administration / American College of Physicians Manual for Assessing Health Practices and Designing Practice Guidelines1 / /
Person
Anna S. Lok / Anna S. F. Lok / J. McMahon / /
Position
advisor / advisor /consultant / Hunter / Girard PM / et al / /
AASLD PRACTICE GUIDELINE UPDATE Chronic Hepatitis B: Update 2009 Anna S. F. Lok1 and Brian J. McMahon2 The 2009 update of the American Association for the Study of Liver Diseases (AASLD) Practice Guidelines for Managemen